BioSpace News Archive

Policy

After Rejection, FDA Grants Fast Track Designation to Diabetes Drug Farxiga

AstraZeneca said the FDA awarded the designation to Farxiga to delay the progression of renal failure and prevent cardiovascular and renal death in patients with chronic kidney disease.

August 27, 2019

·

2 min read

·

Alex Keown

Policy

Oklahoma Pegs J&J with $527 Million Opioid Verdict

Between J&J, Purdue ($270 million), and Israel-based Teva Pharmaceuticals ($85 million), Oklahoma will garner about $927 million – a far cry from the $20 billion the state had been seeking in damages related to the opioid crisis.

August 27, 2019

·

3 min read

·

Alex Keown

BioCapital

Alliance for Regenerative Medicine Issues Guiding Ethical Principles for Gene Editing

The Alliance for Regenerative Medicine, which calls itself an “international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector,” issued a bioethical framework for gene editing’s use in therapeutic applications.

August 27, 2019

·

3 min read

·

Mark Terry

Career Advice

How to Nail Your First Biopharma Interview After College

The first biopharma interview after college will increase your stress and anxiety. However, we offer a few time-tested tips to help you nail your first interview.

August 27, 2019

·

4 min read

·

Don Potochny

Pharm Country

Seeking Small Molecule Drugs to Control mRNA Translation

Wouldn’t it be amazing to be able to see a protein being made in a cell in real time? And wouldn’t it be even better if you could use that capability to discover new drugs to previously “undruggable” targets, creating new medicines? Well that’s exactly what Anima Biotech is aiming to do.

August 27, 2019

·

13 min read

·

Chelsea Weidman Burke

Policy

Local Health Department Approaches to Opioid Use Prevention and Response Featured in New NACCHO Survey

Local Health Departments in Colorado, Kentucky, Maine, Maryland, Massachusetts, Minnesota, Missouri, Nevada, New Hampshire, Ohio, Pennsylvania, Tennessee, and Wisconsin Tell Their Stories

August 27, 2019

·

4 min read

Pharm Country

Alfa Chemistry Offers Metal Nanomaterial Products

On August 25, 2019, Alfa Chemistry announced that they can offer various metal nanomaterial products to meet the different needs of their customers.

August 27, 2019

·

6 min read

Deals

Investment in life sciences innovation at all-time high, driving demand for new real estate concepts

U.S. biopharmaceutical research and development spending reached a record $179 billion in 2018 and is expected to grow by $34 billion by 2024, an indication that companies are investing now to improve their future pipelines, according to JLL’s eighth annual Life Sciences Outlook.

August 27, 2019

·

6 min read

Policy

The Alliance for Regenerative Medicine Releases Statement of Principles on Genome Editing

The Alliance for Regenerative Medicine released a Therapeutic Developers’ Statement of Principles, setting forth a bioethical framework for the use of gene editing in therapeutic applications.

August 27, 2019

·

5 min read

Drug Development

Santhera Announces Publication by ReveraGen of Positive Phase IIa-Extension Study Results with Vamorolone in Patients with Duchenne Muscular Dystrophy

Santhera Pharmaceuticals announces publication by ReveraGen of positive study data with vamorolone in patients with Duchenne muscular dystrophy.

August 27, 2019

·

8 min read